PT Kimia Research Articles

Keragaman Somaklonal untuk Perbaikan Tanaman Artemisia (Artemisia annua L.) melalui Kultur In Vitro

<p>Somaclonal Variability for the Improvement of Plants<br />Artemisia (Artemisia annua L.) by In Vitro Culture.<br />Endang G. Lestari, Rosa Yunita, and Ali Husni. Artemisia<br />annua L., a family member of Asteraceae, is medicinal<br />plants originated from China. The plant has been widely<br />used by the local people for malaria remedy. Its active substance,<br />artemisine, has been proved to hamper the malaria<br />bacteria incubation, Plasmodium sp. In accordance with the<br />WHO recomendation, the Department of Health of Indonesia<br />is now in the attempt of developing this plant as the<br />subtitute of chloroquin because of the malaria bacteria<br />resistance to this antidote. In Indonesia, the artemisine<br />content of the plant less than 0,5% is the crucial problem<br />leading no investors are interested in its economic value.<br />Therefore, Indonesian Medicinal and Spice Crops Research<br />Institute; BPTO Tawangmangu, Indonesian Institute of<br />Sciences; and PT Kimia Farma cooperate for obtaining the<br />prime clone by breeding, selection, as well as environmental<br />adaptation. In coping with the problem, ICABIOGRAD in the<br />collaboration with Bogor Agricultural University have<br />conducted the research for genetic improvement through<br />mutative induction and field selection. This research on<br />somaclonal variation. was conducted from Januari 2006 to<br />Juni 2008. Eksplan used for experiment were shoots radiated<br />with 10-100 Gy gamma ray. The result showed that the shoot<br />radiated with the dosage of 70-100 Gy was unable to grow.<br />On the other hand, the high level of multiplication was<br />acquired in the one radiated with 10-30 Gy. The optimum<br />radiation for somaclonal radiation was eventually gained<br />with 40-60 Gy. The somaclone lines with 10-60 Gy radiation<br />have been aclimatized and planted in Gunung Putri plot in<br />the elevation of 1545 asl. Artemisinin content at the high<br />biomases genotype is 0,49-0,52%.</p>

The Implementation of Strategy, Organizational Culture and Performance: Finding 'The Best Fit'

Objective - The purpose of this empirical study was to examine the degree of alignment between the implementation of strategy and organization's culture, and its implication on company performance. Methodology/Technique - The study is quantitative in nature using survey questionnaires. Total numbers of 201 questionnaires were sent to operational managers of Kimia Farma Pharmacy and 114 questionnaires were returned and analyzed using descriptive analysis with SPSS version 20, and the analysis of Structural Equation Modeling (SEM) with a statistical program AMOS version 7. Findings - The finding of the study shows the implementation of strategy and two types of organizational culture (adhocracy and clan culture) respectively influence the performance of PT Kimia Farma Pharmacy. This study, however, failed to find the best fit between the implementation of strategy and organizational culture in general. Further analysis shows that clan and hierarchy culture become the trigger of the implementation of strategy Novelty - This study proves that clan and hierarchy culture become the trigger of strategy implementation which eventually generate a better performance of the company. Type of Paper - Empirical Keywords: Best Fit; Strategy Implementation; Organizational Culture; Performance.

Optimalisasi Profitabilitas Perusahaan Farmasi melalui Rasio Likuiditas pada PT. Kimia Farma Pekanbaru

Abstract: One important factor to measure the liquidity of a company then used Carrent Variable Ratio of dividing current assets by current liabilities Quick ratio is current assets minus persidiaan divided by current liabilities and inventories to Turn Over ie sales divided by inventory, and to measure the profitability of a companies use Return on Assets (ROA) is net profit after tax in the total asset.Berdasarkan background above problem, then the problem can be formulated as follows whether likuididas conditions significantly affect the level of profitability at PT. Kimia Farma Pekanbaru.Tujuan of research to obtain empirical evidence about whether liquidity significantly affect the level of profitability at PT. Kimia Farma Pekanbau The next test is to compare the profitability value (significance F) and a = 0, 05. SPSS printout of the results shows the probability value of 0.005 which is smaller than 0.05. so Ho is rejected and Ha accepted. This means that variable liquidity conditions significantly affect the condition profitabilitas.Sedangkan when in partial test, print out computer (attached) shows the results of a data analyst and partial hypothesis testing that variable curent Ratio indicates the level of significance of 0.005 which means that small of a = 0.05, so ho rejected and Ha accepted this means the current ratio variable effect on the level of profitability at PT Kimia Farma.
 
 Keywords: Likwiditas dan Profitabilitas

Analisis dan Penilaian Bisnis Perusahaan BUMN di Industri Farmasi: Studi Kasus Kimia Farma dan Indofarma Tahun 2006-2008

The objective of this research were R to determine the financial ratios as a basis to describe the financial performance and compare stock prices to book value (PBV) and evaluate the rate of return between the two companies by using the Du Pont analysis, with the focus for pharmaceutical industries in Indonesia. The benefit to provide an overview of financial performance of both companies. Then predicted to prospective investors on the cheap or expensive a stock. Provide recommendations to potential investors to make investment decisions. The method used is the ratio method and the percentage sales method. The conclusion can be that the performance of Finance at PT Kimia Farma as part of Indonesian pharmaceutical industries largely increased from year to year, while PT Indofarma largely decreased. PT Indofarma stock price is cheaper than PT Kimia Farma. The rate of return is relatively stable PT Kimia Farma and PT Indofarma has decreased from year to year. For the moderate investor PT Kimia Farma is the right choice.